Nationwide Utilization of Danish Government Electronic Letter System for Increasing InFLUenza Vaccine Uptake Among Adults With Chronic Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

299881 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-24

Study Completion Date

2024-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In randomized clinical trials and observational studies, influenza vaccination has been shown to be effective in reducing influenza-related illness, hospitalizations, cardiovascular events, and mortality in select populations. However, the real-world effectiveness of influenza vaccination is limited by its uptake. This study will investigate whether digital behavioral nudges delivered via the official, mandatory Danish electronic letter system can increase influenza vaccine uptake among adults aged 18-64 years with chronic diseases.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Nationwide Utilization of Danish Government Electronic Letter System for Increasing InFLUenza Vaccine Uptake

NCT05542004

Influenza Behavior and Behavior Mechanisms

COMPLETED NA

Nationwide Utilization of Danish Government Electronic Letter System for Confirming the Effectiveness of Behavioral Nudges in Increasing InFLUenza Vaccine Uptake Among Older Adults

NCT06030726

Influenza Behavior and Behavior Mechanisms

COMPLETED NA

Collaborative Efforts to Increase Flu Vaccination

NCT01403649

Influenza Collaboration

COMPLETED NA

Personalized Nudging to Increase Influenza Vaccinations

NCT06566534

Influenza, Human

COMPLETED NA

Precision Vaccine Promotion in Underserved Populations

NCT05537441

Influenza Vaccine Hesitancy

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is a prospective, randomized, open-label implementation trial. The study population will consist of persons aged 18-64 years identified as eligible for free-of-charge influenza vaccination due to a chronic condition. Subjects will be identified through Danish nationwide health registries using codes from the International Classification of Diseases, 10th revision (ICD-10). Individuals will be randomized to 1 of 7 arms (1 usual care arm and 6 intervention arms) with each testing different nudging strategies employing various behavioural economic principles. The interventions will be delivered through the official, mandatory Danish electronic letter system. All subject data will be retrieved from the Danish nationwide registries with the exception of information on intervention allocation. Endpoints will be retrieved at prespecified dates using prespecified search algorithms.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Influenza Behavior and Behavior Mechanisms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Usual Care

No letter

Group Type NO_INTERVENTION

No interventions assigned to this group

Standard Letter

This group will receive a standard letter on the benefits of influenza vaccination without behavioral economic enhancement

Group Type EXPERIMENTAL